SV2C
Basic information
Region (hg38): 5:76083383-76353939
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SV2C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | |||||
missense | 42 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 42 | 11 | 7 |
Variants in SV2C
This is a list of pathogenic ClinVar variants found in the SV2C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-76131781-C-T | SV2C-related disorder | Likely benign (Nov 06, 2019) | ||
5-76131838-G-A | not specified | Uncertain significance (Dec 06, 2021) | ||
5-76131867-T-A | not specified | Uncertain significance (Mar 01, 2024) | ||
5-76131895-T-C | not specified | Uncertain significance (Nov 07, 2022) | ||
5-76131952-G-A | not specified | Uncertain significance (Dec 07, 2021) | ||
5-76132034-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
5-76132055-C-G | not specified | Likely benign (Dec 14, 2023) | ||
5-76132055-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
5-76132110-G-A | SV2C-related disorder | Benign (Oct 16, 2019) | ||
5-76132111-C-T | SV2C-related disorder | Likely benign (Feb 07, 2022) | ||
5-76132219-G-A | not specified | Uncertain significance (Jun 13, 2023) | ||
5-76132245-C-T | Benign (Apr 24, 2018) | |||
5-76132249-G-A | SV2C-related disorder | Likely benign (Jan 06, 2020) | ||
5-76132264-G-A | not specified | Uncertain significance (Jan 27, 2022) | ||
5-76132299-C-T | SV2C-related disorder | Likely benign (Feb 20, 2019) | ||
5-76132307-C-G | not specified | Uncertain significance (Apr 16, 2024) | ||
5-76132309-A-G | not specified | Uncertain significance (Jun 17, 2024) | ||
5-76132322-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
5-76132339-G-A | Benign (May 18, 2018) | |||
5-76194934-T-A | not specified | Uncertain significance (May 05, 2023) | ||
5-76194967-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
5-76195028-C-A | not specified | Uncertain significance (Jun 17, 2024) | ||
5-76195051-T-C | not specified | Uncertain significance (Aug 02, 2021) | ||
5-76209738-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
5-76209789-G-A | not specified | Uncertain significance (Jul 26, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SV2C | protein_coding | protein_coding | ENST00000502798 | 12 | 270768 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000244 | 1.00 | 125274 | 1 | 77 | 125352 | 0.000311 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.868 | 369 | 419 | 0.881 | 0.0000232 | 4794 |
Missense in Polyphen | 143 | 174.38 | 0.82007 | 1952 | ||
Synonymous | -1.40 | 184 | 161 | 1.14 | 0.00000969 | 1363 |
Loss of Function | 3.28 | 14 | 34.9 | 0.401 | 0.00000166 | 415 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00125 | 0.00125 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000283 | 0.000274 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000187 | 0.000185 |
Middle Eastern | 0.000283 | 0.000274 |
South Asian | 0.000393 | 0.000392 |
Other | 0.000165 | 0.000164 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in the control of regulated secretion in neural and endocrine cells, enhancing selectively low-frequency neurotransmission. Positively regulates vesicle fusion by maintaining the readily releasable pool of secretory vesicles. {ECO:0000250|UniProtKB:Q9Z2I6}.; FUNCTION: (Microbial infection) Possible receptor for C.botulinum neurotoxin type D (BoNT/D, botD); note that type D does not usually infect humans. {ECO:0000269|PubMed:21483489}.;
- Pathway
- ECM-receptor interaction - Homo sapiens (human);Disease;Toxicity of botulinum toxin type A (BoNT/A);Toxicity of botulinum toxin type D (BoNT/D);Toxicity of botulinum toxin type F (BoNT/F);Uptake and actions of bacterial toxins;Neurotoxicity of clostridium toxins;Infectious disease
(Consensus)
Recessive Scores
- pRec
- 0.136
Intolerance Scores
- loftool
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.28
Haploinsufficiency Scores
- pHI
- 0.172
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.495
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.685
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sv2c
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- neurotransmitter transport;chemical synaptic transmission;transmembrane transport
- Cellular component
- plasma membrane;synaptic vesicle;integral component of membrane;cell junction;integral component of synaptic vesicle membrane;synaptic vesicle membrane;neuron projection
- Molecular function
- protein binding;transmembrane transporter activity